{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:49Z","timestamp":1777870429071,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02101-8","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:05:27Z","timestamp":1730718327000},"page":"1171-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and outcomes of kidney transplantation in autosomal dominant polycystic kidney disease patients"],"prefix":"10.1093","volume":"38","author":[{"given":"Jin Hyeog","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyeon","family":"Myung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujin","family":"Gang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jin","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Joon","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"2101_CR1","unstructured":"United States Renal Data System (2023) 2023 Annual Data Report: Ch 1, Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. https:\/\/usrds-adr.niddk.nih.gov\/2023\/end-stage-renal-disease\/1-incidence-prevalence-patient-characteristics-and-treatment-modalities. Accessed 15 March 2024"},{"key":"2101_CR2","unstructured":"European Renal Association (2022) ERA Registry Annual Report 2021. https:\/\/www.era-online.org\/wp-content\/uploads\/2023\/12\/ERA-Registry-Annual-Report-2021_231206.pdf. Accessed 15 March 2024"},{"issue":"10174","key":"2101_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD (2019) Autosomal dominant polycystic kidney disease. Lancet 393(10174):919\u2013935. https:\/\/doi.org\/10.1016\/S0140-6736(18)32782-X","journal-title":"Lancet"},{"issue":"5","key":"2101_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329(5):332\u2013342. https:\/\/doi.org\/10.1056\/NEJM199307293290508","journal-title":"N Engl J Med"},{"issue":"2","key":"2101_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ndt\/gft437","volume":"29","author":"RL Luciano","year":"2014","unstructured":"Luciano RL, Dahl NK (2014) Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 29(2):247\u2013254. https:\/\/doi.org\/10.1093\/ndt\/gft437","journal-title":"Nephrol Dial Transplant"},{"issue":"25","key":"2101_CR6","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E et al (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367(25):2407\u20132418. https:\/\/doi.org\/10.1056\/NEJMoa1205511","journal-title":"N Engl J Med"},{"issue":"20","key":"2101_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G et al (2017) Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 377(20):1930\u20131942. https:\/\/doi.org\/10.1056\/NEJMoa1710030","journal-title":"N Engl J Med"},{"issue":"9","key":"2101_CR8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.ekir.2022.06.006","volume":"7","author":"M Chedid","year":"2022","unstructured":"Chedid M, Kaidbay HD, Wigerinck S, Mkhaimer Y, Smith B, Zubidat D et al (2022) Cardiovascular outcomes in kidney transplant recipients with ADPKD. Kidney Int Rep 7(9):1991\u20132005. https:\/\/doi.org\/10.1016\/j.ekir.2022.06.006","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2101_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone RD, Ruthazer R, Terrin NC (2001) Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 38(4):777\u2013784. https:\/\/doi.org\/10.1053\/ajkd.2001.27720","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2101_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.34067\/KID.0001182019","volume":"2","author":"G Bhutani","year":"2020","unstructured":"Bhutani G, Astor BC, Mandelbrot DA, Mankowsi-Gettle L, Ziemlewicz T, Wells SA et al (2020) Long-term outcomes and prognostic factors in kidney transplant recipients with polycystic kidney disease. Kidney360 2(2):312\u2013324. https:\/\/doi.org\/10.34067\/KID.0001182019","journal-title":"Kidney360"},{"issue":"1","key":"2101_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00007890-199401000-00014","volume":"57","author":"KW Florijn","year":"1994","unstructured":"Florijn KW, Chang PC, Woude FJ, Bockel JH, Saase JL (1994) Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation 57(1):73\u201381. https:\/\/doi.org\/10.1097\/00007890-199401000-00014","journal-title":"Transplantation"},{"issue":"7","key":"2101_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.transproceed.2017.06.014","volume":"49","author":"L Illesy","year":"2017","unstructured":"Illesy L, Kov\u00e1cs D\u00c1, Szab\u00f3 RP, Asztalos L, Nemes B (2017) Autosomal dominant polycystic kidney disease transplant recipients after kidney transplantation: a single-center experience. Transplant Proc 49(7):1522\u20131525. https:\/\/doi.org\/10.1016\/j.transproceed.2017.06.014","journal-title":"Transplant Proc"},{"issue":"20","key":"2101_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"issue":"7","key":"2101_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ki.2008.388","volume":"74","author":"International Summit on Transplant Tourism and Organ Trafficking","year":"2008","unstructured":"International Summit on Transplant Tourism and Organ Trafficking (2008) The Declaration of Istanbul on organ trafficking and transplant tourism. Kidney Int 74(7):854\u2013859. https:\/\/doi.org\/10.1038\/ki.2008.388","journal-title":"Kidney Int"},{"issue":"9","key":"2101_CR15","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1111\/ajt.12850","volume":"14","author":"A Sharif","year":"2014","unstructured":"Sharif A, Hecking M, Vries APJ, Porrini E, Hornum M, Rasoul-Rockenschaub S et al (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant 14(9):1992\u20132000. https:\/\/doi.org\/10.1111\/ajt.12850","journal-title":"Am J Transplant"},{"issue":"5","key":"2101_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/diagnostics12051174","volume":"12","author":"T Tsung-Yin","year":"2022","unstructured":"Tsung-Yin T, Cheng-Hsu C, Ming-Ju W, Shang-Feng T (2022) Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up. Diagnostics 12(5):1174. https:\/\/doi.org\/10.3390\/diagnostics12051174","journal-title":"Diagnostics"},{"issue":"5","key":"2101_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000989","volume":"6","author":"A Culliford","year":"2020","unstructured":"Culliford A, Phagura N, Sharif A (2020) Autosomal dominant polycystic kidney disease is a risk factor for posttransplantation diabetes mellitus: an updated systematic review and meta-analysis. Transplant Direct 6(5):e553. https:\/\/doi.org\/10.1097\/TXD.0000000000000989","journal-title":"Transplant Direct"},{"key":"2101_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40620-016-0349-7","volume":"29","author":"M Piergiorgio","year":"2016","unstructured":"Piergiorgio M, Carlo MA, Emanuele M, Mariano F, Roberta C (2016) ADPKD: clinical issues before and after renal transplantation. J Nephrol 29:755\u2013763. https:\/\/doi.org\/10.1007\/s40620-016-0349-7","journal-title":"J Nephrol"},{"issue":"1","key":"2101_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1440-1797.2011.01507.x","volume":"17","author":"I Ruderman","year":"2012","unstructured":"Ruderman I, Masterson R, Tates C, Gorelik A, Cohney SJ, Walker RG (2012) New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study. Nephrology (Carlton) 17(1):89\u201396. https:\/\/doi.org\/10.1111\/j.1440-1797.2011.01507.x","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"2101_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ki.1997.360","volume":"52","author":"K Vareesangthip","year":"1997","unstructured":"Vareesangthip K, Tong P, Wilkinson R, Thomas TH (1997) Insulin resistance in adult polycystic kidney disease. Kidney Int 52(2):503\u2013508. https:\/\/doi.org\/10.1038\/ki.1997.360","journal-title":"Kidney Int"},{"issue":"4","key":"2101_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M et al (2013) Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 19(4):488\u2013493. https:\/\/doi.org\/10.1038\/nm.3092","journal-title":"Nat Med"},{"issue":"7","key":"2101_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","volume":"91","author":"S Caillard","year":"2011","unstructured":"Caillard S, Eprinchard L, Perrin P, Braun L, Heibel F, Moreau F et al (2011) Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test. Transplantation 91(7):757\u2013764. https:\/\/doi.org\/10.1097\/TP.0b013e31820f0877","journal-title":"Transplantation"},{"issue":"2","key":"2101_CR23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","volume":"67","author":"AM de Mattos","year":"2005","unstructured":"de Mattos AM, Olyaei A, Prather JC, Golconda MS, Barry JM, Norman DJ (2005) Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 67(2):714\u2013720. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.67132.x","journal-title":"Kidney Int"},{"issue":"3","key":"2101_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.arcmed.2007.10.003","volume":"39","author":"M Pietrzak-Nowacka","year":"2008","unstructured":"Pietrzak-Nowacka M, Safranow K, R\u00f3za\u0144ski J, Debska-Slizie\u0144 A, Doma\u0144ski L, Dziewanowski K et al (2008) Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. matched-pair design multicenter study. Arch Med Res 39(3):312\u20139. https:\/\/doi.org\/10.1016\/j.arcmed.2007.10.003","journal-title":"Arch Med Res"},{"issue":"4","key":"2101_CR25","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/ajt.16316","volume":"21","author":"KA Robin","year":"2021","unstructured":"Robin KA, Jennifer DM, Kyle RJ, Robert AM, Allan BM, Edward SK et al (2021) Quantifying infection risks in incompatible living donor kidney transplant recipients. Am J Transplant 21(4):1564\u20131575. https:\/\/doi.org\/10.1111\/ajt.16316","journal-title":"Am J Transplant"},{"issue":"10","key":"2101_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/tri.12616","volume":"28","author":"S Thomas","year":"2015","unstructured":"Thomas S, Maik S, Petra R (2015) ABO desensitization affects cellular immunity and infection control after renal transplantation. Transpl Int 28(10):1179\u20131194. https:\/\/doi.org\/10.1111\/tri.12616","journal-title":"Transpl Int"},{"key":"2101_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101930","volume":"81","author":"K Zhong-Yu","year":"2023","unstructured":"Zhong-Yu K, Chun L, Wei L, Daihong L (2023) Association between blood transfusion after kidney transplantation and risk for the development of de novo HLA donor-specific antibodies and poor clinical outcomes: a single-center retrospective study. Transpl Immunol 81:101930. https:\/\/doi.org\/10.1016\/j.trim.2023.101930","journal-title":"Transpl Immunol"},{"issue":"6","key":"2101_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/tri.12937","volume":"30","author":"JE Matthew","year":"2017","unstructured":"Matthew JE, Kimberly PB, Carl EH, Georg D, Paul B, Scott AK et al (2017) Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study. Transpl Int 30(6):566\u2013578. https:\/\/doi.org\/10.1111\/tri.12937","journal-title":"Transpl Int"},{"issue":"1","key":"2101_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ndt\/gfv452","volume":"32","author":"AL Marten","year":"2016","unstructured":"Marten AL, Niek FC, Alix G, Ruud GL, Sander VA, Anna ML, Ron TG, Joost PHD (2016) Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transplant 32(1):144\u2013150. https:\/\/doi.org\/10.1093\/ndt\/gfv452","journal-title":"Nephrol Dial Transplant"},{"key":"2101_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-024-01899-7","author":"C Sidar","year":"2024","unstructured":"Sidar C, Lasin O, Mustafa G, Ahmet UT, Mehmet K (2024) Native nephrectomy in polycystic kidney disease patients on transplant lists: how and when? J Nephrol. https:\/\/doi.org\/10.1007\/s40620-024-01899-7","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:56Z","timestamp":1777564736000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/4\/1171\/8457106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2101"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02101-8","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in accordance with the 2000 Declaration of Helsinki [\n                      \n                      ] and the Declaration of Istanbul on organ trafficking and transplant tourism 2008 [\n                      \n                      ]. It was approved by the Institutional Review Boards of Severance Hospital (4\u20132022-0885) and Seoul National University Hospital (H-2208\u2013183-1354), and informed consent was waived owing to the retrospective nature of the study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}